Pfizer Raises Bid for AstraZeneca

Pfizer has raised its bid for AstraZeneca to $84.47 a share, valuing the U.K. drug maker at more than $106 billion, in a fresh bid for AstraZeneca backing.



from WSJ.com: US Business http://ift.tt/1pVDsjm

via IFTTT